Protocol CY 1033: A Multi-Center, Double-Blind, Randomized, Placebo-Controlled Trial to Assess Efficacy and Safety of Omecamtiv Mecarbil in Patients with Symptomatic Heart Failure with Severely Reduced Ejection Fraction

Project: Research project

Project Details

StatusActive
Effective start/end date6/26/25 → 6/25/26

Funding

  • Cytokinetics ( Award # ): $16,560.00